TAKE LIMITED (NSE:TAKE)
India · Delayed Price · Currency is INR 12.92
0.00 (0.00%)
Nov 11, 2026, 2:40 PM IST
TAKE LIMITED Revenue
TAKE LIMITED had revenue of 303.73M INR in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 845.59M. In the fiscal year ending March 31, 2026, TAKE LIMITED had annual revenue of 541.85M. That makes TAKE LIMITED the 37,859th largest company in the world by revenue and 3,394th in India.
Revenue (ttm)
845.59M
Revenue Growth
n/a
P/S Ratio
2.27
Revenue / Employee
169.12M
Employees
5
Market Cap
1.91B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 541.85M | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | 36.02M | -1.85B | -98.09% |
| Mar 31, 2023 | 1.89B | -4.64B | -71.03% |
| Mar 31, 2022 | 6.53B | -1.21B | -15.68% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 616.31B |
| Divi's Laboratories | 121.91B |
| Lenskart Solutions | 103.83B |
| Laurus Labs | 78.23B |
| Vaidya Sane Ayurved Laboratories | 1.17B |
| Quest Laboratories | 1.12B |
| Par Drugs and Chemicals | 1.08B |
| Sotac Pharmaceuticals | 1.01B |